Market Size – USD 20.52 Billion in 2021, Market Growth – at a CAGR of 7.4%, Market Trends – High Rate of Women Opting for Egg Bank
NEW YORK, NEW YORK, USA, August 9, 2022 /EINPresswire.com/ —
Growing demand for ART procedures such as egg banking, frozen donor services, and IVF, among others, and rising incidence of infertility are driving the revenue growth of the ART market
The Assisted Reproductive Technologies (ART) Market The size is expected to reach USD 39.12 billion in 2030 and register a CAGR of 7.4% during the forecast period, according to the latest report from Reports and Data. Rising demand for surrogacy by the LGBTQIA+ community and rising success rates of in vitro fertilization (IVF) and related ART procedures are driving the market revenue growth.
Infertility can be treated with ART. ART helps treat infertility by providing a variety of procedures that a patient can choose from depending on their needs and medical history. The most popular and effective type of ART is in vitro fertilization (IVF). Donor eggs, donor sperm or frozen embryos are popular services used by ART patients. Surrogacy is a major driver of market growth as more and more people move beyond the social stigma associated with it and focus on the benefits it provides.
Key companies profiled in the report include
Cosmos Biomedical Ltd., Microm UK Ltd., CooperSurgical Fertility Solutions, FUJIFILM Irvine Scientific, Cryolab Ltd., Parallabs Ltd., European Sperm Bank, OvaScience, Inc., Bloom IVF and Ferring Pharmaceuticals.
Get a sample report @ https://www.reportsanddata.com/sample-enquiry-form/1402
The report is an investigative study that determines market growth and market scope based on market trends, changes in consumer behavior, consumption and production patterns, product portfolio offered by the market , growth rate, drivers and restraints, financial positions, and existing challenges and limitations of Assisted Reproductive Technologies (ART) Market.
The report discusses in detail the global production capacity, demand-supply relationship, market dynamics and a comprehensive analysis of the competitive landscape. It provides an industry-wide analysis of each player’s market share along with their business portfolio, production and manufacturing capacity, product portfolio, expansion plans business, financial condition and strategic alliances such as mergers and acquisitions, joint ventures and collaborations, among others.
Order this report @ https://www.reportsanddata.com/report-pricing/1402
The regional bifurcation of the market analyzes key market segments such as North America, Latin America, Europe, Asia-Pacific, Middle East and Africa. The report examines in detail market growth, market size, revenue growth, market share, production and consumption, demand and supply, current and emerging trends and technological developments in each region. .
The major geographical regions analyzed in the market report are:
North America (USA, Canada)
Europe (UK, Italy, Germany, France, Rest of EU)
Asia-Pacific (India, Japan, China, South Korea, Australia, rest of APAC)
Latin America (Chile, Brazil, Argentina, Rest of Latin America)
Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa, Rest of MEA)
Assisted Reproductive Technologies (ART) Market Segment By Type:
Type Technology Outlook (Revenue, USD Billion; 2019-2030)
Induction of ovulation
Procedural Outlook (Revenue, USD Billion; 2019-2030)
Procedural Technology Outlook (Revenue, USD Billion; 2019-2030)
In vitro fertilization
IVF with intracytoplasmic sperm injection (ICSI)
IVF without ICSI
Artificial insemination-Intrauterine insemination
Replacement of frozen embryos
End-Use Outlook (Revenue, USD Billion; 2019-2030)
Some highlights of the report
In February 2021, TMRW Life Sciences announced the release of the world’s first automated Cryo sample management solution for eggs and embryos used in IVF procedures. The TMRW platform has been launched in a number of fertility clinics across the United States, enabling the management of millions of embryos and eggs used in modern IVF.
The egg/embryo bank segment accounted for a significantly large revenue share in 2021. Women are born with a limited number of eggs they can have and as they age, their eggs decrease. Women who are bound by tight work schedules and do not have time to bear a child due to their career or for any other reason, but who still want to be a mother at some point in their life, prefer the egg/embryo bank where their eggs are frozen and safely stored under controlled conditions. They can use their stored eggs to conceive at a time of their choosing.
The frozen embryo replacement (FER) segment accounted for a significantly large revenue share in 2021. Embryo freezing improvements, including the vitrification procedure, have increased the frequency of delayed frozen embryo transfers. The benefits of delayed embryo transfer include reducing pregnancy risks associated with fresh embryo transfer IVF cycles, allowing the environment of the uterus to recover after egg harvest, and enabling genetic testing.
The market in North America is expected to grow at a steady rate during the forecast period. This is due to increased public awareness of various fertility alternatives, government support for in vitro fertilization to counter the social stigma surrounding ART, and other technological and procedural advances.
Request a customization on the report @ https://www.reportsanddata.com/request-customization-form/1402
Thank you for reading our report. For more information or questions about customization, please contact us for more information. Our team will clear your doubts and ensure that the report is customized to meet your requirements.
About reports and data
Reports and Data is a market research and consulting firm that provides syndicated research reports, custom research reports and consulting services. Our solutions are uniquely focused on your goal to locate, target and analyze changes in consumer behavior across demographics, across industries and help customers make a smarter business decision. We offer market intelligence research ensuring relevant, fact-based research across multiple sectors including healthcare, technology, chemicals, power and energy. We are constantly updating our search offerings to ensure that our clients are aware of the latest trends existing in the market. Reports and Data has a strong base of experienced analysts in various areas of expertise.